Oculus Innovative Sciences Launches New Dermatology Division - Quick Facts

(RTTNews) - Oculus Innovative Sciences, Inc. (OCLS) said it has launched a new division, IntraDerm Pharmaceuticals, which is intended to develop and commercialize advanced dermatological products for the professional dermatology markets in the U.S. and internationally.

The company noted that IntraDerm Pharmaceuticals, headquartered in Petaluma, California, is staffed with a seasoned management and sales team who are well versed in the dermatology prescription markets in both the U.S. and Europe.

IntraDerm's first U.S. products are - Alevicyn Antipruritic Gel, which is for use by healthcare professionals in the management of pain, burning and itching associated with various dermatoses; and Alevicyn Dermal Spray, for use by health care professionals in the management via debridement of wounds.

The Alevicyn products were launched in late 2014. A second product offering, Celacyn Prescription Scar Management Gel, is being launched this month throughout the U.S.